FDA DEVICE FACTS
Health Line CT CVC
Health Line International Corporation
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The HEALTH LINE CT CVC is indicated for short term (less than 30 days) access to the central venous system for intravenous administration of fluids, medications, blood products, and/or nutritional therapy solutions when prescribed. Blood sampling and power injection of contrast media may also be conducted with the HEALTH LINE CT CVC.
TECHNOLOGICAL COMPARISON TO PREDICATE DEVICE:
The HEALTH LINE CT CVC is IDENTICAL to the predicate device the OrionTM II CT CVC (K113622) in ALL aspects except:
New labeling, Instructions for use (IFU) (with additional instructions), addition suture wing components (to provide clinicians with additional options, if desired) in the kit configuration. Catheter length – Exactly same as predicate. Insertion site – Exactly the same as predicate OrionTM II CT CVC and is placed in a central vein. Dwell time – Exactly the same as predicate OrionTM II CVC is indicated for short term access.
The changes do not impact the performance or safety and effectiveness of the device compared to the predicate. The HEALTH LINE CT CVC subject device and the predicate device OrionTM II CT CVC (K113622) are manufactured by the same company, Health Line International Corporation, the submitter of this submission.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。